Pharmacokinetics of enrofloxacin administered intravenously and orally to foals
- 1 June 2000
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 61 (6), 706-709
- https://doi.org/10.2460/ajvr.2000.61.706
Abstract
Objective—To determine the pharmacokinetics of enrofloxacin administered IV and orally to foals. Animals—5 clinically normal foals. Procedure—A 2-dose cross-over trial with IV and oral administration was performed. Enrofloxacin was administered once IV (5 mg/kg of body weight) to 1-week-old foals, followed by 1 oral administration (10 mg/kg) after a 7-day washout period. Blood samples were collected for 48 hours after the single dose IV and oral administrations and analyzed for plasma enrofloxacin and ciprofloxacin concentrations by use of high-performance liquid chromatography. Results—For IV administration, mean ± SD total area under the curve (AUC0-∞) was 48.54 ± 10.46 µg · h/ml, clearance was 103.72 ± 0.06 ml/kg/h, halflife (t1/2β) was 17.10 ± 0.09 hours, and apparent volume of distribution was 2.49 ± 0.43 L/kg. For oral administration, AUC0-∞ was 58.47 ± 16.37 µg · h/ml, t1/2β was 18.39 ± 0.06 hours, maximum concentration (Cmax) was 2.12 ± 00.51 µg/ml, time to Cmax was 2.20 ± 2.17 hours, mean absorption time was 2.09 ± 0.51 hours, and bioavailability was 42 ± 0.42%. Conclusions and Clinical Relevance—Compared with adult horses given 5 mg of enrofloxacin/kg IV, foals have higher AUC0-∞, longer t1/2β, and lower clearance. Concentration of ciprofloxacin was negligible. Using a target Cmax to minimum inhibitory concentration ratio of 1:8 to 1:10, computer modeling suggests that 2.5 to 10 mg of enrofloxacin/kg administered every 24 hours would be effective in foals, depending on minimum inhibitory concentration of the pathogen. (Am J Vet Res 2000;61: 706–709)Keywords
This publication has 18 references indexed in Scilit:
- Pharmacokinetics of enrofloxacin in newborn and one‐week‐old calvesJournal of Veterinary Pharmacology and Therapeutics, 1997
- Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administrationEquine Veterinary Journal, 1997
- The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to OutcomeClinical Pharmacokinetics, 1995
- Update on Neonatal SepticemiaVeterinary Clinics of North America: Equine Practice, 1994
- In‐vitro susceptibility to antimicrobial drugs of bacterial isolates from horses in The NetherlandsEquine Veterinary Journal, 1993
- Book Review: Toxins and Targets. Effects of Natural and Synthetic Poisons on Living Cells and Fragile Ecosystems. D. Watters, M. Lavin, D. Maguire, and J. Pearn, Editors. Chur (Switzerland): Hardwood Academic Publishers. 199 pp, 60 Figures, 16 Tables, $39.00Toxicologic Pathology, 1992
- Passive Role of Articular Chondrocytes in Quinolone-Induced Arthropathy in Guinea PigsToxicologic Pathology, 1990
- Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistanceAntimicrobial Agents and Chemotherapy, 1987
- Pharmacologic Considerations in Drug Therapy in FoalsVeterinary Clinics of North America: Equine Practice, 1987
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978